Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 1.000 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.508 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.507 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.506 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.506 | |
| 3nie | ANP | Mitogen-activated protein kinase | / | 0.497 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.495 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.495 | |
| 2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.489 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.487 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.485 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.484 | |
| 4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.484 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.484 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.480 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.476 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.476 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.476 | |
| 5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.475 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.473 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.473 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.471 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.469 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.464 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.463 | |
| 4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.463 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.463 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.461 | |
| 4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.461 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.460 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.459 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.459 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.459 | |
| 4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.457 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.457 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.457 | |
| 4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.455 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.455 | |
| 2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.454 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.454 | |
| 1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 1jnk | ANP | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.452 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.451 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.451 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.450 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.449 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.449 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.448 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.448 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.448 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.448 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 1ydt | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
| 3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.447 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.447 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.447 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.444 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.443 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.442 | |
| 3ork | AGS | Serine/threonine protein kinase | / | 0.442 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.442 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.441 | |
| 3cly | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |